OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE:NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, will announce its third quarter 2015 results on Wednesday, 21 October 2015.
Help employers find you! Check out all the jobs and
